APA

Walsh T. J., Yeldandi V., McEvoy M., Gonzalez C., Chanock S., Freifeld A., Seibel N. I., Whitcomb P. O., Jarosinski P., Boswell G., Bekersky I., Alak A., Buell D., Barret J. & Wilson W. (19981022). Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. : Antimicrobial agents and chemotherapy.

Chicago

Walsh T J, Yeldandi V, McEvoy M, Gonzalez C, Chanock S, Freifeld A, Seibel N I, Whitcomb P O, Jarosinski P, Boswell G, Bekersky I, Alak A, Buell D, Barret J and Wilson W. 19981022. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. : Antimicrobial agents and chemotherapy.

Harvard

Walsh T. J., Yeldandi V., McEvoy M., Gonzalez C., Chanock S., Freifeld A., Seibel N. I., Whitcomb P. O., Jarosinski P., Boswell G., Bekersky I., Alak A., Buell D., Barret J. and Wilson W. (19981022). Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. : Antimicrobial agents and chemotherapy.

MLA

Walsh T J, Yeldandi V, McEvoy M, Gonzalez C, Chanock S, Freifeld A, Seibel N I, Whitcomb P O, Jarosinski P, Boswell G, Bekersky I, Alak A, Buell D, Barret J and Wilson W. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. : Antimicrobial agents and chemotherapy. 19981022.